scientific article published on 01 February 1997

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • наукова стаття, опублікована в лютому 1997 (uk)
  • im Februar 1997 veröffentlichter wissenschaftlicher Artikel (de)
  • artículu científicu espublizáu en febreru de 1997 (ast)
  • artikull shkencor i botuar më 01 shkurt 1997 (sq)
  • scientific article published on 01 February 1997 (en)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
author name string
  • A D Hess
  • J M Davis
  • R J Jones
  • K Schepers
  • S J Noga
rdfs:label
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (en)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (nl)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (sq)
skos:prefLabel
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (en)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (nl)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (sq)
name
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (en)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (nl)
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (sq)
author
author
title
title
  • CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity (en)
page(s)
page(s)
  • 728-732
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 9123500
published in
published in
issue
volume
issue
  • 1-2
volume
  • 29
DOI
DOI
DOI
  • 10.1016/S0041-1345(96)00442-3
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software